Biblio
] , “Western-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeys”, Fertility and Sterility, vol. 105, no. 4, pp. 1023 - 1034, 2016.
, “The effects of luteinizing hormone ablation/replacement versus steroid ablation/replacement on gene expression in the primate corpus luteum”, Molecular Human Reproduction, vol. 15231331381492275864795711841419183118123613088451173699013603789696731191148107081010, no. 3228115101116411512566136224639235341191985, pp. 181 - 193, 2009.
, “Dynamics of Immune Cell Types Within the Macaque Corpus Luteum During the Menstrual Cycle: Role of Progesterone1”, Biology of Reproduction, vol. 93964912961013137367951511593371228971942215015238172188414196446115701761131366159244112744541167238692094180881391213786156565, no. 5, 2015.
, “Microarray analysis of the primate luteal transcriptome during chorionic gonadotrophin administration simulating early pregnancy”, MHR: Basic science of reproductive medicine, vol. 1811121571171391492215014957811419012332311601160491157694150151568382859911351229611217, no. 4, pp. 216 - 227, 2011.
, “Non-genomic actions of progesterone and estrogens in regulating reproductive events in domestic animals.”, Vet J, vol. 176, no. 3, pp. 270-80, 2008.
, “Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys”, Journal of Ovarian Research, vol. 103338326171387143209031451066514212414149333279571181961236205949314173139239289627768213716881676712312133141, no. 1, 2017.
, “Effects of steroid ablation and progestin replacement on the transcriptome of the primate corpus luteum during simulated early pregnancy”, MHR: Basic science of reproductive medicine, vol. 201112157117181391492215071326313657795714125821511418093445315011608849150637552691441770108695, no. 3, pp. 222 - 234, 2013.
, “Analysis of microarray data from the macaque corpus luteum; the search for common themes in primate luteal regression”, Molecular Human Reproduction, vol. 17361582139149221501944911020465684117121802562804951501283161237342111771019958, no. 32311153216353142512611365822512396181 Suppl Proceedings, pp. 143 - 151, 2011.
, “Chronic hyperandrogenemia and western-style diet beginning at puberty reduces fertility and increases metabolic dysfunction during pregnancy in young adult, female macaques”, Human Reproduction, vol. 3393429677108333836185112611196622791322410404811211651291131867329834115, no. 4Suppl. 2, pp. 694 - 705, 2018.
, “Progesterone suppresses an oxytocin-stimulated signal pathway in COS-7 cells transfected with the oxytocin receptor”, Steroids, vol. 73, no. 14, pp. 1367 - 1374, 2008.
, “Changes in immune cell distribution and their cytokine/chemokine production during regression of the rhesus macaque corpus luteum†”, Biology of Reproduction, vol. 961343141151149912961011611393174622123922150151726141448510912688251117791344141912474708968185425217685113220, no. 6, pp. 1210 - 1220, 2017.
, “Quantification of dynamic changes to blood volume and vascular flow in the primate corpus luteum during the menstrual cycle”, Journal of Medical Primatology, vol. 433395839043712243841429931713714138154128908474, no. 6Suppl 8, pp. 445 - 454, 2014.
, “Non-genomic actions of progesterone and estrogens in regulating reproductive events in domestic animals”, The Veterinary Journal, vol. 176, no. 3, pp. 270 - 280, 2008.
, “Knockdown of Progesterone Receptor (PGR) in Macaque Granulosa Cells Disrupts Ovulation and Progesterone Production1”, Biology of Reproduction, vol. 94151414097933484432385953983354791541726412218172015181115355102829123509425573193465597616515268, no. 5, 2016.
, “Progesterone inhibition of oxytocin signaling in endometrium”, Frontiers in Neuroscience, vol. 7, 2013.
, “Evaluation of antral follicle growth in the macaque ovary during the menstrual cycle and controlled ovarian stimulation by high-resolution ultrasonography”, American Journal of Primatology, vol. 7127698025286881002132211351227250712107, no. 5, pp. 384 - 392, 2009.
, “Editorial: computational chemogenomics in drug design and discovery.”, Current topics in medicinal chemistry, vol. 12, p. 1867, 2012.
, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands”, Journal of medicinal chemistry, vol. 52, pp. 5635–5641, 2009.
“Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs”, Proceedings of the National Academy of Sciences, vol. 104, pp. 11927–11932, 2007.
, “Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons”, Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018, pp. 473 - 510.
, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.”, J Med Chem, vol. 52, no. 18, pp. 5635-41, 2009.
, “Binding Properties of the C-terminal Domain of VIAF”, Chemical biology & drug design, vol. 72, pp. 331–336, 2008.
, “Ligand selectivity for the acetylcholine binding site of the rat $\alpha$4$\beta$2 and $\alpha$3$\beta$4 nicotinic subtypes investigated by molecular docking”, Journal of medicinal chemistry, vol. 48, pp. 5123–5130, 2005.
, “Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes $\alpha$4$\beta$2 and $\alpha$7”, Journal of molecular modeling, vol. 14, pp. 891–899, 2008.
, “Drug repurposing in chemical genomics: can we learn from the past to improve the future?”, Current topics in medicinal chemistry, vol. 12, pp. 1883–1888, 2012.